BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
Nuovi dati su ICS/LABA/LAMA vs LABA/LAMA per la BPCO • NCF
Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease - ScienceDirect
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the d | COPD
Chronic obstructive pulmonary disease (COPD) - Management Approach | BMJ Best Practice
Approved fixed-dose combinations of LABAs and LAMAs for COPD treatment | Download Scientific Diagram
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box | European Respiratory Society
PDF] Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA | Semantic Scholar
Population-based study of LAMA monotherapy effectiveness compared with LABA/ LAMA as initial treatment for COPD in primary care | npj Primary Care Respiratory Medicine
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
Frontiers | Single Inhaler LABA/LAMA for COPD
American College of Chest Physicians - In a real-world setting, LAMA-LABA-ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
A new alphabet for COPD care | European Respiratory Society
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine